As seen previously with AcES treatment in experimental colitis, AIP-1 promoted the production of IL-10, suggesting a potential mechanism of systemic regulation of inflammation.38 A similar observation was made upon analysis of the colonic mucosa in which the levels of IL-10 were significantly elevated in comparison to vehicle-treated mice but also in comparison with naïve control. Here, IL10 is linked to colitis.